Form 4: Select Medical Holdings CFO Reports Merger-Related Share Transactions

Michael F. Malatesta, CFO of Select Medical Holdings Corp., reported transactions related to the company's merger agreement, exchanging shares for interests in the acquiring entity.

Summary

• This filing is a Form 4, reporting changes in beneficial ownership of securities.
• Michael F. Malatesta, Chief Financial Officer of Select Medical Holdings Corp. (SEM), reported a transaction on June 30, 2026.
• The transaction involved the disposition of common stock and restricted shares as part of an Agreement and Plan of Merger.
• Malatesta contributed 79,723 common shares and 158,334 restricted shares to Stallion Intermediate Corporation (Parent) in exchange for equivalent shares of Parent's common stock and restricted shares.
• These Parent shares were subsequently exchanged for interests in Stallion Group Parent, LP.
• Following these transactions, Malatesta beneficially owns 238,057 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports on a standard post-merger share exchange by an executive rather than new financial performance or strategic shifts.

Positives

• The CFO's participation in the merger indicates alignment with the company's strategic direction.
• The exchange of shares for interests in the acquiring entity suggests a continuation of involvement post-merger.

Negatives

• The filing details the disposition of securities, which could be interpreted as a reduction in direct ownership of the original entity's stock.

Risks

• The merger itself introduces integration risks and potential changes in business strategy that could impact future performance.
• The exact nature and value of the 'interests in Stallion Group Parent, LP' are not detailed, introducing uncertainty regarding the ultimate beneficial ownership value.

Future Outlook

The filing does not contain forward-looking statements or guidance. The transactions are related to a completed merger event.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions, particularly during significant corporate events like mergers. This filing provides transparency into how key executives are navigating the transition.

Stakeholder Impact

• Shareholders: The merger impacts the structure of their investment, with shares of Select Medical Holdings Corp. being exchanged for interests in the acquiring entity.
• Employees: Potential changes in employment terms or roles may arise from the merger.
• Management: The CFO's transaction reflects their participation in the merger's equity restructuring.

Next Steps

• The merger is effective, and the exchange of securities has occurred.
• Further filings may be required to detail ongoing beneficial ownership in the new corporate structure.

Key Dates

Keywords

Form 4, SEC Filing, Select Medical Holdings Corp, SEM, Michael F. Malatesta, CFO, Merger Agreement, Beneficial Ownership, Stock Transaction, Stallion Intermediate Corporation